Stay updated with breaking news from Second Line Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 -- HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be...
Investegate announcements from HUTCHMED Presentations at 2024 ASCO Annual Meeting
A survey of pediatric dermatologists revealed that topical corticosteroids are the most common first-line treatment for children with alopecia areata, regardless of age or hair loss severity.
Experts on follicular lymphoma discuss second-line treatment options available for patients.
Recent decades have seen marked improvements in hematological cancer outcomes and an expanded armamentarium of therapies, but novel treatments require updated strategies that are not always easy to fine-tune, according to presenters at the 2023 American Society of Hematology Annual Meeting and Exposition.